NeoGenomics, Inc.
(NASDAQ : NEO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Medical Or Nursing Services
symbolcompany%chnglast%shortavg$volume
SDCSmileDirectClub, Inc. 11.67%6.700.0%$135.93m
GHGuardant Health, Inc. 3.99%132.050.0%$105.00m
OPCHOption Care Health, Inc. 0.78%25.750.0%$93.34m
NVTAInvitae Corp. 6.09%31.551.1%$91.73m
OSHOak Street Health, Inc. 1.55%52.540.0%$90.98m
CANOCano Health, Inc. -0.32%15.390.0%$81.40m
NTRANatera, Inc. 4.98%126.361.1%$72.92m
DVADaVita, Inc. 0.35%121.683.7%$69.58m
AMEDAmedisys, Inc. 1.25%171.1311.4%$56.45m
FLGTFulgent Genetics, Inc. 6.53%91.710.6%$45.45m
CHEChemed Corp. -0.51%475.6610.2%$41.05m
ONEM1Life Healthcare, Inc. 6.12%25.160.0%$39.11m
LHCGLHC Group, Inc. 2.04%168.972.9%$37.28m
NEONeoGenomics, Inc. 1.98%48.325.1%$35.77m
ACHCAcadia Healthcare Co., Inc. 3.13%61.2226.8%$27.00m

Company Profile

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.